tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Uy Ear, 36 are a HOLD (26.28%), 100 are a BUY (72.99%), 1 are a SELL (0.73%).
Analyst Uy Ear, currently employed at MIZUHO, carries an average stock price target met ratio of 32.99% that have a potential upside of 30.7% achieved within 164 days.
Uy Ear’s has documented 247 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALKS, Alkermes Plc at 02-Jul-2026.
Analyst best performing recommendations are on QURE (UNIQURE NV).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS) at 1/2/2024. The price target of $8 was fulfilled within 45 days with a profit of $4.57 (133.24%) receiving and performance score of 29.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Feb-2020
$38
$12.84 (51.03%)
$35
1 months 27 days ago
(06-Aug-2026)
1/3 (33.33%)
$11.57 (43.78%)
27
Buy Since 20-Nov-2021
$38
$12.84 (51.03%)
$18
1 months 27 days ago
(06-Aug-2026)
3/11 (27.27%)
$11.57 (43.78%)
252
Buy Since 07-Sep-2022
$40
$14.84 (58.98%)
$36
1 months 27 days ago
(06-Aug-2026)
19/25 (76%)
$13.57 (51.34%)
443
Buy Since 23-Feb-2024
$35
$8 (29.63%)
$37
7 months 1 days ago
(02-Mar-2026)
9/27 (33.33%)
$10.24 (41.36%)
345
Buy Since 07-Aug-2025
$35
$8 (29.63%)
$30
7 months 7 days ago
(26-Feb-2026)
2/3 (66.67%)
$6.43 (22.51%)
55
Which stock is Uy Ear most bullish on?
Which stock is Uy Ear most reserved on?
What Year was the first public recommendation made by Uy Ear?
